BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 10098431)

  • 41. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
    Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.
    Barillot I; Horiot JC; Pigneux J; Schraub S; Pourquier H; Daly N; Bolla M; Rozan R
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):969-78. PubMed ID: 9276361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
    Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
    Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis.
    Sakurai H; Mitsuhashi N; Takahashi M; Akimoto T; Muramatsu H; Ishikawa H; Imai R; Yamakawa M; Hasegawa M; Niibe H
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1136-44. PubMed ID: 11483322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
    Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
    Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
    Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.
    Lanciano RM; Won M; Coia LR; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):667-76. PubMed ID: 2004942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).
    Kim H; Kim YS; Joo JH; Eom KY; Park W; Kim JH; Lee JH; Kim YS; Lee SH; Ahn K; Kim YB; Lee MY; Chang SK
    Int J Gynecol Cancer; 2018 Feb; 28(2):371-378. PubMed ID: 29189448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone.
    Pedersen D; Søgaard H; Overgaard J; Bentzen SM
    Acta Oncol; 1995; 34(6):787-95. PubMed ID: 7576747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.